Evidence map›Paper›PMID 35464666›Full record

ArticleKnowledge-based systems2022

BCOVIDOA: A Novel Binary Coronavirus Disease Optimization Algorithm for Feature Selection.

Asmaa M Khalid, Hanaa M Hamza, Seyedali Mirjalili, Khalid M Hosny

Abstract read
In one paragraph

Article in Knowledge-based systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Asmaa M KhalidDepartment of Information Technology, Faculty of Computers and Informatics, Zagazig University, Zagazig 44519, Egypt.
Hanaa M HamzaDepartment of Information Technology, Faculty of Computers and Informatics, Zagazig University, Zagazig 44519, Egypt.
Seyedali MirjaliliCentre for Artificial Intelligence Research and Optimization, Torrens University Australia, Fortitude Valley, Brisbane 4006, QLD, Australia.
Khalid M HosnyDepartment of Information Technology, Faculty of Computers and Informatics, Zagazig University, Zagazig 44519, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increased use of digital tools such as smart phones, Internet of Things devices, cameras, and microphones, has led to the produuction of big data. Large data dimensionality, redundancy, and irrelevance are inherent challenging problems when it comes to big data. Feature selection is a necessary process to select the optimal subset of features when addressing such problems. In this paper, the authors propose a novel Binary Coronavirus Disease Optimization Algorithm (BCOVIDOA) for feature selection, where the Coronavirus Disease Optimization Algorithm (COVIDOA) is a new optimization technique that mimics the replication mechanism used by Coronavirus when hijacking human cells. The performance of the proposed algorithm is evaluated using twenty-six standard benchmark datasets from UCI Repository. The results are compared with nine recent wrapper feature selection algorithms. The experimental results demonstrate that the proposed BCOVIDOA significantly outperforms the existing algorithms in terms of accuracy, best cost, the average cost (AVG), standard deviation (STD), and size of selected features. Additionally, the Wilcoxon rank-sum test is calculated to prove the statistical significance of the results.

Indexed as

Best costBig dataConvergenceCoronavirusEvolutionary algorithmFeature selectionFrameshiftingMeta-heuristicOptimization

Identifiers

PMID35464666
PMCPMC9014647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.